Docetaxel vs non‐docetaxel‐containing regimens
Tumour response · people with advanced gastric cancer
Docetaxel leads to higher tumour response ‐ Additive comparison compared with non‐docetaxel‐containing regimens (high certainty).
1 finding from 1 review
- OR 1.83 [1.45, 2.32]4 studies · 1235 participantsHigh